SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-068889
Filing Date
2024-06-04
Accepted
2024-06-04 17:23:52
Documents
1
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10674
  Complete submission text file 0000950170-24-068889.txt   12130
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FUSION PHARMACEUTICALS INC. 270 LONGWOOD RD. SOUTH HAMILTON Z4 L8P 0A6
Business Address
Bobilev Dmitri (Reporting) CIK: 0001952201 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39344 | Film No.: 241019546